Atherosclerosis

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD

Physician’s Briefing

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD

07 Aug 2026

1 min read

Considerable Gaps Identified in LDL Cholesterol Control

Physician’s Briefing

Considerable Gaps Identified in LDL Cholesterol Control

03 Aug 2026

2 min read

Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status

Physician’s Briefing

Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status

30 Jul 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com